MIST RSI Chart
Last 7 days
9.1%
Last 30 days
-4.5%
Last 90 days
3.1%
Trailing 12 Months
-53.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 5.5M | 6.0M | 4.5M | 1.0M |
2022 | 11.7M | 0 | 8.3M | 5.0M |
2021 | 4.3M | 7.9M | 11.4M | 15.0M |
2020 | 2.5M | 2.0M | 1.2M | 726.0K |
2019 | 1.2M | 1.7M | 2.1M | 2.6M |
2018 | 0 | 0 | 0 | 711.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 22, 2023 | rtw investments, lp | sold | - | - | -1,059,000 | - |
Dec 05, 2022 | bharucha david | bought | 32,830 | 4.69 | 7,000 | chief medical officer |
Dec 01, 2022 | bharucha david | bought | 14,580 | 4.86 | 3,000 | chief medical officer |
Oct 21, 2022 | liebert debra k. | bought | 21,040 | 5.26 | 4,000 | - |
Oct 20, 2022 | pasternak richard c | bought | 52,000 | 5.2 | 10,000 | - |
Oct 20, 2022 | liebert debra k. | bought | 52,900 | 5.29 | 10,000 | - |
Oct 19, 2022 | wills robert james | bought | 73,950 | 4.93 | 15,000 | - |
Oct 19, 2022 | tomsicek michael john | bought | 79,800 | 5.32 | 15,000 | - |
Sep 14, 2022 | liebert debra k. | acquired | - | - | 127 | - |
Sep 07, 2022 | rtw investments, lp | bought | 13,564,500 | 8.71 | 1,557,350 | - |
Which funds bought or sold MIST recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 01, 2024 | BNP PARIBAS FINANCIAL MARKETS | added | 177 | 20,064 | 30,251 | -% |
May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Apr 26, 2024 | Clear Creek Financial Management, LLC | reduced | -21.26 | -8,273 | 44,750 | 0.01% |
Apr 25, 2024 | Valeo Financial Advisors, LLC | unchanged | - | -100 | 16,600 | -% |
Apr 25, 2024 | SIMPLEX TRADING, LLC | reduced | -55.99 | -1,000 | - | -% |
Apr 24, 2024 | BML Capital Management, LLC | added | 37.03 | 346,272 | 1,085,000 | 0.72% |
Mar 12, 2024 | PVG ASSET MANAGEMENT CORP | added | 25.41 | -15,491 | 32,264 | 0.16% |
Mar 08, 2024 | ICA Group Wealth Management, LLC | new | - | 334 | 334 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 5.76 | -3,412,800 | 4,519,240 | -% |
Feb 26, 2024 | Virtu Financial LLC | new | - | 31,000 | 31,000 | -% |
Unveiling Milestone Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Milestone Pharmaceuticals Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 47.9B | 6.8B | -8.03 | 7 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.3B | 2.0B | -58.02 | 9.62 | ||||
BMRN | 15.7B | 2.5B | 76.24 | 6.34 | ||||
INCY | 12.1B | 3.8B | 16.19 | 3.2 | ||||
MID-CAP | ||||||||
APLS | 5.7B | 396.6M | -10.82 | 14.42 | ||||
BBIO | 5.2B | 107.9M | -9.53 | 48.09 | ||||
AXSM | 3.5B | 270.6M | -14.81 | 13.09 | ||||
ARWR | 3.0B | 240.7M | -10.2 | 12.18 | ||||
ACAD | 2.8B | 726.4M | -45.79 | 3.86 | ||||
SMALL-CAP | ||||||||
CPRX | 1.7B | 398.2M | 24.31 | 4.36 | ||||
NVAX | 687.2M | 983.7M | -1.26 | 0.7 | ||||
CRBP | 408.0M | 881.7K | -9.15 | 466.16 | ||||
INO | 282.8M | 4.9M | -2.09 | 58.11 | ||||
IBIO | 6.9M | 2.1M | -0.25 | 2.14 |
Milestone Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | - | - | - | - | 1,000,000 | 3,500,000 | 1,500,000 | 750,000 | - | - | 15,000,000 | 7,548,000 | 96,000 | 89,000 | 126,000 | 415,000 | 603,000 | 821,000 | 672,000 | 500,000 | 292,500 | 85,000 |
S&GA Expenses | -20.3% | 3,371,000 | 4,227,000 | 4,445,000 | 3,889,000 | 4,123,000 | 4,034,000 | 3,643,000 | 3,787,000 | 2,961,000 | 3,018,000 | 2,633,000 | 1,674,000 | 2,952,000 | 2,956,000 | 2,703,000 | 2,279,500 | 2,104,000 | 1,641,000 | 979,000 | 1,217,500 | 646,000 |
R&D Expenses | -18.9% | 5,452,000 | 6,721,000 | 8,622,000 | 10,257,000 | 10,578,000 | 9,826,000 | 8,768,000 | 10,916,000 | 9,733,000 | 9,427,000 | 8,595,000 | 5,766,000 | 8,228,000 | 8,622,000 | 11,872,000 | 14,148,500 | 9,545,000 | 10,527,000 | 7,765,000 | 7,296,500 | 3,911,000 |
EBITDA Margin | -Infinity% | -57.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -100.0% | - | 841,000 | 820,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | -17,000 | - | - | -1,000 | -73,000 | -4,000 | 22,000 | 56,000 | - |
Earnings Before Taxes | - | - | - | - | - | - | - | - | -16,884,000 | -14,225,000 | - | - | -8,666,000 | -11,996,000 | -12,979,000 | -16,343,000 | -18,289,000 | -12,904,000 | -13,662,000 | -10,430,000 | -9,660,000 | -5,700,000 |
EBT Margin | -360.0% | -59.68 | -12.98 | -9.73 | -10.62 | -11.68 | -6.21 | -4.44 | -3.45 | -4.19 | -6.36 | -11.64 | -68.85 | - | - | - | - | - | - | - | - | - |
Net Income | 9.7% | -13,611,000 | -15,081,000 | -16,043,000 | -14,950,000 | -13,177,000 | -14,556,000 | -14,007,000 | -16,884,000 | -14,225,000 | 770,000 | -12,514,000 | -8,666,000 | -11,979,000 | -12,979,000 | -16,343,000 | -18,288,000 | -12,831,000 | -13,658,000 | -10,452,000 | -9,716,000 | -5,700,000 |
Net Income Margin | -353.3% | -59.68 | -13.17 | -9.79 | -10.79 | -11.68 | -7.45 | -3.80 | -2.86 | -3.03 | -4.12 | -10.74 | -68.83 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 19.3% | -9,827,000 | -12,178,000 | -10,595,000 | -13,936,000 | -12,972,000 | -11,676,000 | -14,050,000 | -12,478,000 | -9,493,000 | 914,000 | -12,571,000 | -8,858,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -13.6% | 75.00 | 87.00 | 97.00 | 111 | 74.00 | 86.00 | 91.00 | 106 | 120 | 134 | 145 | 138 | 150 | 109 | 93.00 | 105 | 123 | 142 | 152 | 78.00 | 88.00 |
Current Assets | -13.9% | 73.00 | 85.00 | 95.00 | 109 | 72.00 | 83.00 | 91.00 | 105 | 119 | 133 | 144 | 137 | 149 | 107 | 92.00 | 104 | 122 | 141 | 152 | 77.00 | 88.00 |
Cash Equivalents | 39.3% | 14.00 | 10.00 | 33.00 | 74.00 | 8.00 | 37.00 | 63.00 | 92.00 | 114 | 111 | 98.00 | 72.00 | 72.00 | 47.00 | 53.00 | 102 | 120 | 107 | 111 | 71.00 | 86.00 |
Net PPE | 1.8% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | -0.3% | 58.00 | 59.00 | 57.00 | 57.00 | 8.00 | 9.00 | 5.00 | 5.00 | 7.00 | 6.00 | 6.00 | 6.00 | 7.00 | 7.00 | 5.00 | 6.00 | 9.00 | 9.00 | 7.00 | 4.00 | 5.00 |
Current Liabilities | -10.9% | 7.00 | 8.00 | 7.00 | 8.00 | 6.00 | 7.00 | 4.00 | 5.00 | 7.00 | 6.00 | 5.00 | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 8.00 | 9.00 | 6.00 | 4.00 | 5.00 |
Long Term Debt | 1.8% | 50.00 | 49.00 | 48.00 | 47.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -41.2% | 17.00 | 29.00 | 40.00 | 54.00 | 66.00 | 77.00 | 87.00 | 101 | 113 | 127 | 140 | 132 | 143 | 102 | 88.00 | 100 | 115 | 133 | 145 | 73.00 | 84.00 |
Retained Earnings | -4.3% | -326 | -312 | -297 | -281 | -266 | -251 | -237 | -220 | -207 | -189 | -175 | -175 | -163 | -154 | -142 | -129 | -113 | -95.21 | -82.38 | -68.72 | -58.27 |
Additional Paid-In Capital | 5.9% | 34.00 | 32.00 | 29.00 | 27.00 | 24.00 | 22.00 | 20.00 | 18.00 | 16.00 | 14.00 | 12.00 | 10.00 | 9.00 | 7.00 | 6.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Shares Outstanding | 0.0% | 33.00 | 33.00 | 33.00 | 33.00 | 34.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | 96.00 | - | - | - | 185 | - | - | - | 164 | - | - | - | 93.00 | - | - | - | 218 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 19.4% | -9,796 | -12,160 | -10,564 | -13,904 | -12,862 | -11,573 | -14,085 | -13,949 | -12,377 | -9,392 | 1,015 | -12,470 | -8,757 | -7,334 | -16,562 | -18,079 | -16,603 | -8,298 | -11,518 | -14,733 | -7,311 |
Share Based Compensation | -34.6% | 1,877 | 2,872 | 2,492 | 2,293 | 2,143 | 2,380 | 2,411 | 2,114 | 1,975 | 2,024 | 1,912 | 1,368 | 1,430 | 1,343 | 1,191 | 981 | 354 | 350 | 276 | 211 | 344 |
Cashflow From Investing | 226.0% | 13,676 | -10,857 | -28,031 | 29,968 | -17,015 | -17,050 | -15,059 | -8,000 | 15,000 | 23,000 | 20,000 | 12,000 | -14,000 | -24,000 | - | - | 29,899 | 4,706 | - | - | 8,985 |
Cashflow From Financing | -99.7% | 1.00 | 305 | -2,767 | 50,253 | 227 | 2,672 | 140 | 49.00 | 92.00 | 24.00 | 4,920 | 19.00 | 48,157 | 24,818 | 172 | 77.00 | 21.00 | -731 | 86,092 | 25.00 | 80,078 |
Buy Backs | - | - | - | - | 14,115 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 13,760 | $ 7,636 |
Short-term investments | 52,243 | 56,949 |
Research and development tax credits receivable | 643 | 331 |
Prepaid expenses | 3,178 | 6,005 |
Other receivables | 3,208 | 882 |
Total current assets | 73,032 | 71,803 |
Operating lease right-of-use assets | 1,917 | 2,423 |
Property and equipment | 277 | 257 |
Total assets | 75,226 | 74,483 |
Current liabilities | ||
Accounts payable and accrued liabilities | 6,680 | 5,644 |
Operating lease liabilities | 546 | 495 |
Total current liabilities | 7,226 | 6,139 |
Operating lease liabilities, net of current portion | 1,457 | 1,996 |
Senior secured convertible notes | 49,772 | |
Total liabilities | 58,455 | 8,135 |
Shareholders' Equity | ||
Common shares, no par value, unlimited shares authorized 33,483,111 shares issued and outstanding as of December 31, 2023, 34,286,002 shares issued and outstanding as of December 31, 2022 | 260,504 | 273,900 |
Pre-funded warrants - 9,577,257 issued and outstanding as of December 31, 2023 and 8,518,257 as of December 31, 2022 | 48,459 | 34,352 |
Additional paid-in capital | 33,834 | 24,437 |
Accumulated deficit | (326,026) | (266,341) |
Total shareholders' equity | 16,771 | 66,348 |
Total liabilities and shareholders' equity | $ 75,226 | $ 74,483 |